Fumarylacetoacetase
Fumarylacetoacetate hydrolase | ||
---|---|---|
![]() |
||
Ribbon model of the mouse FAA with Ca 2+ (yellow), Ni 2+ (orange), products (purple) according to PDB 1QCO | ||
Properties of human protein | ||
Mass / length primary structure | 46.4 kDa / 419 amino acids | |
Secondary to quaternary structure | Homodimer | |
Cofactor | Ca 2+ , Mg 2+ | |
Identifier | ||
Gene names | FAH ; FAA | |
External IDs | ||
Enzyme classification | ||
EC, category | 3.7.1.2 , hydrolase | |
Response type | hydrolysis | |
Substrate | 4-fumarylacetoacetate + H 2 O | |
Products | Fumarate + acetoacetate | |
Occurrence | ||
Homology family | Fumarylacetoacetate hydrolase | |
Parent taxon | Creature | |
Orthologue | ||
human | House mouse | |
Entrez | 2184 | 14085 |
Ensemble | ENSG00000103876 | ENSMUSG00000030630 |
UniProt | P16930 | P35505 |
Refseq (mRNA) | NM_000137 | NM_010176 |
Refseq (protein) | NP_000128 | NP_034306 |
Gene locus | Chr 15: 80.15 - 80.19 Mb | Chr 7: 84.59 - 84.61 Mb |
PubMed search | 2184 |
14085
|
Fumarylacetoacetase (FAA, FAH) is the name of the enzyme that hydrolyzes 4-fumarylacetoacetate into fumarate and acetoacetate . This reaction is the last step in the breakdown of the amino acid tyrosine and is carried out in all living things. A lack or absence of the enzyme in humans results in a metabolic disease , the Type I tyrosinemia . The cause is always a mutation in the FAH gene that codes for the enzyme .
biosynthesis
FAA is mainly produced in the liver and kidneys , but also to a small extent in any other tissue . The FAH gene is located on chromosome 15 and comprises 33,340 base pairs and 14 exons . After transcription , mRNA is produced with a length of 1,447 bases, the translation of which results in a protein with 419 amino acids .
Catalyzed reaction
Fumarylacetoacetate is hydrolyzed to fumarate and acetoacetate, the enzyme also needs calcium and magnesium ions as cofactors . FAA is also able to hydrolyze other 3,5- and 2,4-dioxocarboxylic acids.